Zhe Zhang, Sen Yang, & Qiming Wang. (2019). Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer. BMC.
Chicago Style (17th ed.) CitationZhe Zhang, Sen Yang, and Qiming Wang. Impact of MET Alterations on Targeted Therapy with EGFR-tyrosine Kinase Inhibitors for EGFR-mutant Lung Cancer. BMC, 2019.
MLA (9th ed.) CitationZhe Zhang, et al. Impact of MET Alterations on Targeted Therapy with EGFR-tyrosine Kinase Inhibitors for EGFR-mutant Lung Cancer. BMC, 2019.
Warning: These citations may not always be 100% accurate.